1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 21 SEPTEMBER 2015

Cancer Drug News 21 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Biologic Investment Sets AstraZeneca On Course For Long-Term Growth
Industry Brief - BriaCell Initiates Development Of BriaDx Companion Diagnostic
Industry Brief - FDA Accepts Amgen's Kyprolis sNDA For Priority Review In Relapsed MM
Industry Brief - TG/FDA Reach SPA Agreement On Phase III Combination Study In CLL
Industry Brief - ERYTECH Seeks EU Approval For Graspa In ALL
Industry Brief - EMA Grants SL-401 ODD For AML
Industry Brief - sNDA For Imbruvica In CLL Submitted To FDA
Industry Brief - Oxis Licenses Worldwide Rights For DT2219ARL
Industry Brief - US FDA Grants Priority Review For Daratumumab For Multiple Myeloma
Industry Brief - RedHill Secures SBIR Grant For Yeliva Phase II MM Study
Industry Brief - Takeda's Ixazomib Granted Priority Review for r/r MM
Industry Brief - FDA Grants Priority Review for Ofatumumab As Relapsed CLL Maintenance Therapy
Industry Brief - New Data Support Rationale Behind OncoMed's Tarextumab
Industry Brief - Transgene Presents OS Data From TG4010 Phase IIb NSCLC Trial
Industry Brief - Helsinn/Bial Sign Anamorelin Licensing Deal In Select Territories
Industry Brief - FDA Grants Genentech's Alectinib Priority Review For ALK+ NSCLC
Industry Brief - FDA Grants Breakthrough Therapy Designation To Opdivo For Advanced RCC
Industry Brief - FDA Grants Fast Track Designation To BioCancell's BC-819
Industry Brief - Enumeral Achieves First Milestone In Merck Collaboration
Industry Brief - Masitinib Gains ODD For Oesophagogastric Adenocarcinoma
Industry Brief - Can-Fite's CF102 Gains FDA Fast Track Designation For HCC
Industry Trend Analysis - Liquid Biopsy Market Gaining Momentum
Industry Trend Analysis - Amgen Pipeline Needs To Increase Generation Of Marketable Products
Industry Trend Analysis - Oncology Therapies To See Strong Demand Ahead
Industry Brief - Cancer Research UK/MedImmune Launch Biotherapeutics Research Centre
Industry Brief - Janssen Seeks Daratumumab Approval In Europe For MM
Industry Brief - Kancera/Acturum Sign Deal To Evaluate AZD8797
Industry Brief - Agenus Raises Cash To Advance Immuno-Oncology Programmes
Industry Brief - Taj Accura Expands Global Oncology Portfolio
Industry Brief - Dosing Begins In BIND-014 Phase II Trial In Four Tumour Histologies
Industry Brief - Enrolment Completed In Adcetris Phase III CTCL Trial
Industry Brief - Akynzeo Launched In UK
Industry Brief - FDA Accepts Wellstat's Uridine Triacetate NDA For Review
Industry Brief - FDA Accepts Sustol NDA For Review
Industry Brief - AstraZeneca/University Of Manchester Sign Clinical Bioinformatics Deal
Industry Brief - Cancer Conferences - November/December 2015

Table Of Contents

Cancer Drug News 21 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 10125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.